Innate Pharma (IPHA) Change in Working Capital (2018 - 2025)
Innate Pharma posted quarterly Change in Working Capital of -$2328.1 for Q4 2025, down 168.56% on a QoQ basis from $3395.9 in Q2 2025.
Innate Pharma (IPHA) has 8 years of Change in Working Capital data on file, last reported at -$2328.1 in Q4 2025.
- For the quarter ending Q4 2025, Change in Working Capital changed N/A year-over-year to -$2328.1; the trailing twelve-month figure through Dec 2025 stood at -$2328.1 (changed N/A YoY), and the FY2025 full-year result was -$2328.1, down 109.08% from the prior year.
- Change in Working Capital for Q4 2025 stood at -$2328.1, down from $3395.9 in the prior quarter.
- Across five years, Change in Working Capital topped out at $27999.1 in Q2 2024 and bottomed at -$1.8 million in Q2 2021.
- The 5-year median for Change in Working Capital is -$2328.1 (2025), against an average of -$450428.1.
- The widest annual swing landed in 2021, when Change in Working Capital slumped 347.63%; it then soared 328.54% in 2024.
- A 5-year view of Change in Working Capital shows it stood at -$1.4 million in 2021, then jumped by 95.91% to -$55486.9 in 2022, then soared by 111.77% to $6533.5 in 2023, then jumped by 328.54% to $27999.1 in 2024, then slumped by 108.31% to -$2328.1 in 2025.
- The last three Change in Working Capital figures came in at -$2328.1 (Q4 2025), $3395.9 (Q2 2025), and $27999.1 (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Working Capital (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | - |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | - |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | - |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | - |
| 10 | Innate Pharma | 199.64 Mn | 199.64 Mn | - | -2,328.09 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2,328.09 |
| Dec 31, 2025 | -2,328.09 |
| Jun 30, 2025 | 3,395.88 |
| Jun 30, 2025 | 3,395.88 |
| Jun 30, 2024 | 27,999.08 |
| Jun 30, 2024 | 27,999.08 |
| Jun 30, 2023 | 6,533.55 |
| Jun 30, 2023 | 6,533.55 |
| Jun 30, 2022 | -55,486.95 |
| Jun 30, 2022 | -55,486.95 |
| Dec 31, 2021 | -1.36 Mn |
| Dec 31, 2021 | -1.36 Mn |
| Jun 30, 2021 | -1.78 Mn |
| Jun 30, 2021 | -1.78 Mn |
| Dec 31, 2020 | -302,841.62 |
| Dec 31, 2020 | -302,841.62 |
| Jun 30, 2020 | -410,844.63 |
| Jun 30, 2020 | -410,844.63 |
| Jun 30, 2019 | -356,193.59 |
| Jun 30, 2019 | -356,193.59 |
| Dec 31, 2018 | -53.76 Mn |
| Dec 31, 2018 | -53.76 Mn |